A detailed history of Bellevue Group Ag transactions in Medtronic PLC stock. As of the latest transaction made, Bellevue Group Ag holds 1,008,633 shares of MDT stock, worth $81.7 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
1,008,633
Previous 1,001,747 0.69%
Holding current value
$81.7 Million
Previous $78.8 Million 15.17%
% of portfolio
1.53%
Previous 1.32%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.84 - $91.03 $529,120 - $626,832
6,886 Added 0.69%
1,008,633 $90.8 Million
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $413,463 - $457,116
-5,253 Reduced 0.52%
1,001,747 $78.8 Million
Q1 2024

May 15, 2024

BUY
$82.84 - $88.09 $3 Million - $3.19 Million
36,228 Added 3.73%
1,007,000 $87.8 Million
Q4 2023

Feb 14, 2024

BUY
$69.43 - $83.43 $22.9 Million - $27.5 Million
329,280 Added 51.33%
970,772 $80 Million
Q3 2023

Nov 14, 2023

SELL
$78.22 - $90.4 $60.2 Million - $69.5 Million
-769,000 Reduced 54.52%
641,492 $50.3 Million
Q2 2023

Aug 14, 2023

BUY
$79.47 - $91.38 $14.4 Million - $16.6 Million
181,257 Added 14.75%
1,410,492 $124 Million
Q1 2023

May 15, 2023

BUY
$76.72 - $87.58 $46.9 Million - $53.5 Million
610,815 Added 98.77%
1,229,235 $99.1 Million
Q4 2022

Feb 14, 2023

BUY
$76.18 - $87.74 $189,992 - $218,823
2,494 Added 0.4%
618,420 $48.1 Million
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $2.39 Million - $2.82 Million
-29,580 Reduced 4.58%
615,926 $49.7 Million
Q2 2022

Aug 11, 2022

SELL
$87.4 - $113.09 $919,797 - $1.19 Million
-10,524 Reduced 1.6%
645,506 $57.9 Million
Q1 2022

May 13, 2022

SELL
$100.58 - $112.38 $1.14 Million - $1.28 Million
-11,378 Reduced 1.7%
656,030 $72.8 Million
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $32.7 Million - $41.9 Million
328,283 Added 96.8%
667,408 $69 Million
Q3 2021

Nov 12, 2021

SELL
$122.75 - $135.17 $2.52 Million - $2.77 Million
-20,500 Reduced 5.7%
339,125 $42.5 Million
Q2 2021

Aug 12, 2021

BUY
$118.19 - $131.5 $3.2 Million - $3.56 Million
27,103 Added 8.15%
359,625 $44.6 Million
Q1 2021

May 12, 2021

SELL
$111.18 - $119.74 $14.3 Million - $15.4 Million
-128,736 Reduced 27.91%
332,522 $39.3 Million
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $37.2 Million - $43.4 Million
-370,192 Reduced 44.52%
461,258 $54 Million
Q3 2020

Nov 16, 2020

SELL
$90.13 - $108.78 $13.2 Million - $15.9 Million
-146,073 Reduced 14.94%
831,450 $86.4 Million
Q2 2020

Aug 13, 2020

BUY
$84.11 - $103.33 $2.71 Million - $3.33 Million
32,207 Added 3.41%
977,523 $89.6 Million
Q1 2020

May 14, 2020

BUY
$72.92 - $121.3 $7.07 Million - $11.8 Million
96,986 Added 11.43%
945,316 $85.2 Million
Q4 2019

Feb 14, 2020

BUY
$104.49 - $114.54 $4.25 Million - $4.66 Million
40,692 Added 5.04%
848,330 $96.2 Million
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $2.77 Million - $3.14 Million
28,227 Added 3.62%
807,638 $87.7 Million
Q2 2019

Aug 14, 2019

BUY
$84.15 - $99.38 $24.3 Million - $28.7 Million
288,505 Added 58.77%
779,411 $75.9 Million
Q1 2019

May 15, 2019

SELL
$82.45 - $93.79 $456,773 - $519,596
-5,540 Reduced 1.12%
490,906 $44.7 Million
Q3 2018

Nov 13, 2018

BUY
$85.91 - $99.17 $8.12 Million - $9.38 Million
94,565 Added 23.53%
496,446 $48.8 Million
Q2 2018

Aug 07, 2018

BUY
$77.48 - $87.83 $3.48 Million - $3.94 Million
44,881 Added 12.57%
401,881 $34.4 Million
Q1 2018

May 09, 2018

BUY
$76.55 - $87.26 $10.7 Million - $12.2 Million
140,000 Added 64.52%
357,000 $28.6 Million
Q3 2017

Nov 13, 2017

SELL
$77.71 - $84.6 $6.88 Million - $7.49 Million
-88,500 Reduced 28.97%
217,000 $16.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
305,500
305,500 $27.1 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $108B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.